Maria Oliva-Hemker

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Takeda
    Topic:
    vedolizumab
    Date added:
    03/22/2022
    Date updated:
    03/22/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Predict Immune
    Topic:
    IBD biomarker
    Date added:
    03/22/2022
    Date updated:
    03/22/2022
  • Attribution:
    Self
    Type of financial relationship:
    Gift
    Ineligible company:
    Janssen
    Topic:
    consultant drug board
    Date added:
    03/22/2022
    Date updated:
    03/22/2022
Return to 152 Pediatric Grand Rounds: “Advances in the Management of Pediatric Inflammatory Bowel Disease ” (040622)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.